CRISPR Therapeutics AG short interest in 2022
In 2022, CRISPR Therapeutics AG's disclosed short interest ran from 11.15% of shares outstanding on 14 Jan 2022 to 13.39% on 30 Dec 2022, a change of +2.24 percentage points. The year's high was 16.02% on 31 Oct 2022 and its low 10.72% on 31 Jan 2022, averaging 13.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.65 days on 30 Nov 2022. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 11.15% (14 Jan 2022)
- End of year
- 13.39% (30 Dec 2022)
- Change
- +2.24 pp
- High
- 16.02% (31 Oct 2022)
- Low
- 10.72% (31 Jan 2022)
- Average
- 13.49%
- Highest days to cover
- 14.65 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 11.15% | 5.26 | |
| 31 Jan 2022 | 10.72% | 3.88 | |
| 15 Feb 2022 | 11.33% | 6.00 | 10-K filed, results (8-K) |
| 28 Feb 2022 | 11.89% | 6.23 | |
| 15 Mar 2022 | 12.18% | 6.13 | |
| 31 Mar 2022 | 13.04% | 6.08 | |
| 14 Apr 2022 | 13.47% | 9.19 | |
| 29 Apr 2022 | 13.16% | 9.31 | |
| 13 May 2022 | 14.23% | 6.30 | 10-Q filed, results (8-K) |
| 31 May 2022 | 13.21% | 8.51 | |
| 15 Jun 2022 | 13.73% | 5.72 | |
| 30 Jun 2022 | 14.62% | 3.23 | |
| 15 Jul 2022 | 14.88% | 4.69 | |
| 29 Jul 2022 | 14.16% | 8.05 | |
| 15 Aug 2022 | 13.74% | 8.48 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 13.95% | 10.08 | |
| 15 Sep 2022 | 14.02% | 9.91 | |
| 30 Sep 2022 | 14.82% | 9.53 | |
| 14 Oct 2022 | 15.08% | 11.33 | |
| 31 Oct 2022 | 16.02% | 12.51 | |
| 15 Nov 2022 | 14.86% | 9.69 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 14.23% | 14.65 | |
| 15 Dec 2022 | 11.93% | 8.88 | |
| 30 Dec 2022 | 13.39% | 8.42 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.